Learn about medications for ankylosing spondylitis, including NSAIDs, biologics, DMARDs, and lifestyle tips to manage symptoms effectively.
Key Takeaways
- NSAIDs are the first-line treatment for ankylosing spondylitis.
- Biologic treatments (TNF and IL-17 inhibitors) are the most effective for severe cases.
- DMARDs and JAK inhibitors are additional options if biologics fail or are not tolerated.
- Early and consistent treatment prevents joint damage and disability.
- Combining medication with lifestyle changes yields the best long-term results.
Summary
- Ankylosing spondylitis (AS) is an inflammatory arthritis affecting the spine, causing pain, stiffness, and potential vertebrae fusion.
- Early treatment is crucial to prevent permanent joint damage and disability.
- NSAIDs are the first-line treatment to reduce inflammation and pain for mild to moderate AS symptoms.
- Biologic medications, such as TNF inhibitors and IL-17 inhibitors, are highly effective for severe AS and prevent disease progression.
- TNF inhibitors include Humira, Enbrel, Remicade, Cimzia, and Simponi and work by blocking TNF-alpha protein.
- IL-17 inhibitors like Cosentyx and Taltz are alternatives for patients who do not respond to TNF inhibitors.
- Other options include DMARDs and JAK inhibitors, which may be used if biologics are ineffective or not tolerated.
- Medications carry risks such as infection and organ-related side effects, requiring monitoring.
- Natural treatments like exercise, anti-inflammatory diets, and supplements can complement medication.
- Consistent treatment and early diagnosis improve quality of life and reduce complications like heart disease.











